Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
novartis
3
×
roche
3
×
cancer
clinical trials
europe blog main
europe top stories
gene therapy
genentech
national
san francisco top stories
zolgensma
acquisitions
advanced therapies
atmp
avapritinib
avexis
billy dunn
biogen
bioprocess insider
blueprint medicines
bms
boston
boston blog main
boston top stories
brammer bio
bristol-myers squibb
cancer drugs
capmatinib
car-t
car-t chimeric antigen receptor
catalent
cell & gene
cell gene therapy
cell therapeutics
cell therapies
crispr
What
therapy
3
×
drug
fda
access
address
advanced
approval
approved
approves
atrophy
blueprint
cancer
capacity
car
carries
cell
certain
consolidation
crispr
daily
designed
evrysdi
falcon
focus
friday
gene
genetic
green
home
intended
latest
lights
liquid
medicine
medicines
milestones
muscular
new
oral
pass
Language
unset
Current search:
novartis
×
therapy
×
roche
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019